Corinne Goldsmith Dickinson Center for MS

New York, New York 10029

0 studies enrolling now · 6 studies all time

What they study most

Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive

Studies at this site

• An Observational Biomarker Study in Multiple Sclerosis (MS) Patients — Completed
• Study of Oral Fampridine-SR in Multiple Sclerosis — Completed
• Study of Fampridine-SR Tablets in Multiple Sclerosis Patients — Completed
• Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis — Completed
• Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial — Completed
• Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial — Completed